228 related articles for article (PubMed ID: 20574050)
1. Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients.
Broyl A; Hose D; Lokhorst H; de Knegt Y; Peeters J; Jauch A; Bertsch U; Buijs A; Stevens-Kroef M; Beverloo HB; Vellenga E; Zweegman S; Kersten MJ; van der Holt B; el Jarari L; Mulligan G; Goldschmidt H; van Duin M; Sonneveld P
Blood; 2010 Oct; 116(14):2543-53. PubMed ID: 20574050
[TBL] [Abstract][Full Text] [Related]
2. Predictors of early morbidity and mortality in newly diagnosed multiple myeloma: data from five randomized, controlled, phase III trials in 3700 patients.
Mai EK; Hielscher T; Bertsch U; Salwender HJ; Zweegman S; Raab MS; Munder M; Pantani L; Mancuso K; Brossart P; Beksac M; Blau IW; Dürig J; Besemer B; Fenk R; Reimer P; van der Holt B; Hänel M; von Metzler I; Graeven U; Müller-Tidow C; Boccadoro M; Scheid C; Dimopoulos MA; Hillengass J; Weisel KC; Cavo M; Sonneveld P; Goldschmidt H
Leukemia; 2024 Mar; 38(3):640-647. PubMed ID: 38062124
[TBL] [Abstract][Full Text] [Related]
3. Mass Cytometry reveals unique phenotypic patterns associated with subclonal diversity and outcomes in multiple myeloma.
Baughn LB; Jessen E; Sharma N; Tang H; Smadbeck JB; Long MD; Pearce K; Smith M; Dasari S; Sachs Z; Linden MA; Cook J; Keith Stewart A; Chesi M; Mitra A; Leif Bergsagel P; Van Ness B; Kumar SK
Blood Cancer J; 2023 May; 13(1):84. PubMed ID: 37217482
[TBL] [Abstract][Full Text] [Related]
4. A gene expression signature for high-risk multiple myeloma.
Kuiper R; Broyl A; de Knegt Y; van Vliet MH; van Beers EH; van der Holt B; el Jarari L; Mulligan G; Gregory W; Morgan G; Goldschmidt H; Lokhorst HM; van Duin M; Sonneveld P
Leukemia; 2012 Nov; 26(11):2406-13. PubMed ID: 22722715
[TBL] [Abstract][Full Text] [Related]
5. Initial genome sequencing and analysis of multiple myeloma.
Chapman MA; Lawrence MS; Keats JJ; Cibulskis K; Sougnez C; Schinzel AC; Harview CL; Brunet JP; Ahmann GJ; Adli M; Anderson KC; Ardlie KG; Auclair D; Baker A; Bergsagel PL; Bernstein BE; Drier Y; Fonseca R; Gabriel SB; Hofmeister CC; Jagannath S; Jakubowiak AJ; Krishnan A; Levy J; Liefeld T; Lonial S; Mahan S; Mfuko B; Monti S; Perkins LM; Onofrio R; Pugh TJ; Rajkumar SV; Ramos AH; Siegel DS; Sivachenko A; Stewart AK; Trudel S; Vij R; Voet D; Winckler W; Zimmerman T; Carpten J; Trent J; Hahn WC; Garraway LA; Meyerson M; Lander ES; Getz G; Golub TR
Nature; 2011 Mar; 471(7339):467-72. PubMed ID: 21430775
[TBL] [Abstract][Full Text] [Related]
6. Prediction of high- and low-risk multiple myeloma based on gene expression and the International Staging System.
Kuiper R; van Duin M; van Vliet MH; Broijl A; van der Holt B; El Jarari L; van Beers EH; Mulligan G; Avet-Loiseau H; Gregory WM; Morgan G; Goldschmidt H; Lokhorst HM; Sonneveld P
Blood; 2015 Oct; 126(17):1996-2004. PubMed ID: 26330243
[TBL] [Abstract][Full Text] [Related]
7. IMWG consensus on risk stratification in multiple myeloma.
Chng WJ; Dispenzieri A; Chim CS; Fonseca R; Goldschmidt H; Lentzsch S; Munshi N; Palumbo A; Miguel JS; Sonneveld P; Cavo M; Usmani S; Durie BG; Avet-Loiseau H;
Leukemia; 2014 Feb; 28(2):269-77. PubMed ID: 23974982
[TBL] [Abstract][Full Text] [Related]
8. Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma.
Walker BA; Boyle EM; Wardell CP; Murison A; Begum DB; Dahir NM; Proszek PZ; Johnson DC; Kaiser MF; Melchor L; Aronson LI; Scales M; Pawlyn C; Mirabella F; Jones JR; Brioli A; Mikulasova A; Cairns DA; Gregory WM; Quartilho A; Drayson MT; Russell N; Cook G; Jackson GH; Leleu X; Davies FE; Morgan GJ
J Clin Oncol; 2015 Nov; 33(33):3911-20. PubMed ID: 26282654
[TBL] [Abstract][Full Text] [Related]
9. Clinical value of molecular subtyping multiple myeloma using gene expression profiling.
Weinhold N; Heuck CJ; Rosenthal A; Thanendrarajan S; Stein CK; Van Rhee F; Zangari M; Hoering A; Tian E; Davies FE; Barlogie B; Morgan GJ
Leukemia; 2016 Feb; 30(2):423-30. PubMed ID: 26526987
[TBL] [Abstract][Full Text] [Related]
10. The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models.
Shi L; Campbell G; Jones WD; Campagne F; Wen Z; Walker SJ; Su Z; Chu TM; Goodsaid FM; Pusztai L; Shaughnessy JD; Oberthuer A; Thomas RS; Paules RS; Fielden M; Barlogie B; Chen W; Du P; Fischer M; Furlanello C; Gallas BD; Ge X; Megherbi DB; Symmans WF; Wang MD; Zhang J; Bitter H; Brors B; Bushel PR; Bylesjo M; Chen M; Cheng J; Cheng J; Chou J; Davison TS; Delorenzi M; Deng Y; Devanarayan V; Dix DJ; Dopazo J; Dorff KC; Elloumi F; Fan J; Fan S; Fan X; Fang H; Gonzaludo N; Hess KR; Hong H; Huan J; Irizarry RA; Judson R; Juraeva D; Lababidi S; Lambert CG; Li L; Li Y; Li Z; Lin SM; Liu G; Lobenhofer EK; Luo J; Luo W; McCall MN; Nikolsky Y; Pennello GA; Perkins RG; Philip R; Popovici V; Price ND; Qian F; Scherer A; Shi T; Shi W; Sung J; Thierry-Mieg D; Thierry-Mieg J; Thodima V; Trygg J; Vishnuvajjala L; Wang SJ; Wu J; Wu Y; Xie Q; Yousef WA; Zhang L; Zhang X; Zhong S; Zhou Y; Zhu S; Arasappan D; Bao W; Lucas AB; Berthold F; Brennan RJ; Buness A; Catalano JG; Chang C; Chen R; Cheng Y; Cui J; Czika W; Demichelis F; Deng X; Dosymbekov D; Eils R; Feng Y; Fostel J; Fulmer-Smentek S; Fuscoe JC; Gatto L; Ge W; Goldstein DR; Guo L; Halbert DN; Han J; Harris SC; Hatzis C; Herman D; Huang J; Jensen RV; Jiang R; Johnson CD; Jurman G; Kahlert Y; Khuder SA; Kohl M; Li J; Li L; Li M; Li QZ; Li S; Li Z; Liu J; Liu Y; Liu Z; Meng L; Madera M; Martinez-Murillo F; Medina I; Meehan J; Miclaus K; Moffitt RA; Montaner D; Mukherjee P; Mulligan GJ; Neville P; Nikolskaya T; Ning B; Page GP; Parker J; Parry RM; Peng X; Peterson RL; Phan JH; Quanz B; Ren Y; Riccadonna S; Roter AH; Samuelson FW; Schumacher MM; Shambaugh JD; Shi Q; Shippy R; Si S; Smalter A; Sotiriou C; Soukup M; Staedtler F; Steiner G; Stokes TH; Sun Q; Tan PY; Tang R; Tezak Z; Thorn B; Tsyganova M; Turpaz Y; Vega SC; Visintainer R; von Frese J; Wang C; Wang E; Wang J; Wang W; Westermann F; Willey JC; Woods M; Wu S; Xiao N; Xu J; Xu L; Yang L; Zeng X; Zhang J; Zhang L; Zhang M; Zhao C; Puri RK; Scherf U; Tong W; Wolfinger RD;
Nat Biotechnol; 2010 Aug; 28(8):827-38. PubMed ID: 20676074
[TBL] [Abstract][Full Text] [Related]
11. Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy.
Lohr JG; Stojanov P; Carter SL; Cruz-Gordillo P; Lawrence MS; Auclair D; Sougnez C; Knoechel B; Gould J; Saksena G; Cibulskis K; McKenna A; Chapman MA; Straussman R; Levy J; Perkins LM; Keats JJ; Schumacher SE; Rosenberg M; ; Getz G; Golub TR
Cancer Cell; 2014 Jan; 25(1):91-101. PubMed ID: 24434212
[TBL] [Abstract][Full Text] [Related]
12. Gene signature combinations improve prognostic stratification of multiple myeloma patients.
Chng WJ; Chung TH; Kumar S; Usmani S; Munshi N; Avet-Loiseau H; Goldschmidt H; Durie B; Sonneveld P
Leukemia; 2016 May; 30(5):1071-8. PubMed ID: 26669975
[TBL] [Abstract][Full Text] [Related]
13. Impact of gene expression profiling-based risk stratification in patients with myeloma receiving initial therapy with lenalidomide and dexamethasone.
Kumar SK; Uno H; Jacobus SJ; Van Wier SA; Ahmann GJ; Henderson KJ; Callander NS; Haug JL; Siegel DS; Greipp PR; Fonseca R; Rajkumar SV
Blood; 2011 Oct; 118(16):4359-62. PubMed ID: 21860025
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profile alone is inadequate in predicting complete response in multiple myeloma.
Amin SB; Yip WK; Minvielle S; Broyl A; Li Y; Hanlon B; Swanson D; Shah PK; Moreau P; van der Holt B; van Duin M; Magrangeas F; Pieter Sonneveld P; Anderson KC; Li C; Avet-Loiseau H; Munshi NC
Leukemia; 2014 Nov; 28(11):2229-34. PubMed ID: 24732597
[TBL] [Abstract][Full Text] [Related]
15. The genetic architecture of multiple myeloma.
Morgan GJ; Walker BA; Davies FE
Nat Rev Cancer; 2012 Apr; 12(5):335-48. PubMed ID: 22495321
[TBL] [Abstract][Full Text] [Related]
16. Clonal competition with alternating dominance in multiple myeloma.
Keats JJ; Chesi M; Egan JB; Garbitt VM; Palmer SE; Braggio E; Van Wier S; Blackburn PR; Baker AS; Dispenzieri A; Kumar S; Rajkumar SV; Carpten JD; Barrett M; Fonseca R; Stewart AK; Bergsagel PL
Blood; 2012 Aug; 120(5):1067-76. PubMed ID: 22498740
[TBL] [Abstract][Full Text] [Related]
17. Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides.
Egan JB; Shi CX; Tembe W; Christoforides A; Kurdoglu A; Sinari S; Middha S; Asmann Y; Schmidt J; Braggio E; Keats JJ; Fonseca R; Bergsagel PL; Craig DW; Carpten JD; Stewart AK
Blood; 2012 Aug; 120(5):1060-6. PubMed ID: 22529291
[TBL] [Abstract][Full Text] [Related]
18. Primary myeloma interaction and growth in coculture with healthy donor hematopoietic bone marrow.
Bam R; Khan S; Ling W; Randal SS; Li X; Barlogie B; Edmondson R; Yaccoby S
BMC Cancer; 2015 Nov; 15():864. PubMed ID: 26545722
[TBL] [Abstract][Full Text] [Related]
19. Bortezomib induction and maintenance treatment in patients with newly diagnosed multiple myeloma: results of the randomized phase III HOVON-65/ GMMG-HD4 trial.
Sonneveld P; Schmidt-Wolf IG; van der Holt B; El Jarari L; Bertsch U; Salwender H; Zweegman S; Vellenga E; Broyl A; Blau IW; Weisel KC; Wittebol S; Bos GM; Stevens-Kroef M; Scheid C; Pfreundschuh M; Hose D; Jauch A; van der Velde H; Raymakers R; Schaafsma MR; Kersten MJ; van Marwijk-Kooy M; Duehrsen U; Lindemann W; Wijermans PW; Lokhorst HM; Goldschmidt HM
J Clin Oncol; 2012 Aug; 30(24):2946-55. PubMed ID: 22802322
[TBL] [Abstract][Full Text] [Related]
20. Common genetic variants in 11q13.3 and 9q22.33 are associated with molecular subgroups of multiple myeloma.
Erickson SW; Stephens OW; Chavan SS; Tian E; Epstein J; Barlogie B; Heuck CJ; Vangsted AJ
Leukemia; 2015 Dec; 29(12):2418-21. PubMed ID: 26308770
[No Abstract] [Full Text] [Related]
[Next] [New Search]
